Florin M. Selaru

Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.

Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions.

Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer.

Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers.

Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon.

Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.

An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma.

The impact of microsatellite instability on the molecular phenotype of colorectal tumors.

Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors.

An unsupervised approach to identify molecular phenotypic components influencing breast cancer features.

Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning.

Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression.

Prediction of survival in patients with esophageal carcinoma using artificial neural networks.

The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.

Electronic clinical challenges and images in GI. Fibrolamellar carcinoma.

Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma.

Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapy.

Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.

Gastrointestinal stromal tumor causing obscure-occult gastrointestinal bleeding.

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.

A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.

Epigenetic events in gastrointestinal cancer.

Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.

Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation.

Enzymatically triggered actuation of miniaturized tools.

Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.

Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.

MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.

Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma.

MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.

Coordinated effects of microRNA-494 induce Gâ‚‚/M arrest in human cholangiocarcinoma.

Biopsy with thermally-responsive untethered microtools.

Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch.

MicroRNA-224 Negatively Regulates p21 Expression During Late Neoplastic Progression in Inflammatory Bowel Disease.

Biologic tissue sampling with untethered microgrippers.

Connecting the dots from fatty acids to nonalcoholic steatohepatitis: epigenetics in the spotlight.

miRNA-Based Therapeutic Strategies.

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.

Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.

Stimuli-responsive theragrippers for chemomechanical controlled release.

Reply: To PMID 21858175.

Reply: To PMID 24497320.

MicroRNAs in the biology and diagnosis of cholangiocarcinoma.

Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma.

MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer.

The genome-wide gene expression profiling to predict competitive endogenous RNA network in hepatocellular cancer.

Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.